Chronic Pain Science: Advanced Glycation End Products

TL;DR

Advanced glycation end products (AGEs) form when excess glucose binds to proteins in your body in an uncontrolled, irreversible reaction. Over time, these damaged proteins accumulate in joints, muscles, nerves, and connective tissue, altering structure and function. This contributes to stiffness, poor healing, chronic inflammation, and nerve hypersensitivity. What this means for patients is that chronic pain is not just structural; it is often driven by biochemical processes, many of which are heavily influenced by blood sugar and metabolism.

What Patients Are Usually Told

If you are dealing with chronic pain, you have likely been given a familiar set of explanations. You are told your pain is due to inflammation. You are told there is degeneration or “wear and tear.” You may even be told your nerves are “overactive” or “hypersensitive.”

On the surface, all of this sounds reasonable. Imaging may show structural changes. Inflammation can be measured. And nerves can absolutely become more sensitive over time.

But this is where the explanation becomes incomplete. None of these answers explain why your tissues are breaking down, why inflammation persists, or why your nervous system becomes hyperexcitable in the first place.

Where That Explanation Breaks Down

The problem with most chronic pain explanations is not that they are wrong. It is that they stop at the level of symptoms.

They describe what is happening, but not what is driving it. And when you stop at symptoms, treatment naturally becomes focused on suppressing those symptoms—pain medications, anti-inflammatories, injections, or surgery.

Sometimes these approaches help temporarily. But often, the pain returns.

What many patients are never told is that chronic pain is frequently driven by underlying biochemical dysfunction that is not visible on imaging and is not addressed in standard care.

Symptoms Are Signals, Not the Problem

Pain is not the problem. Pain is the symptom.

Your brain produces pain to tell you that something in the body is not functioning correctly.

This distinction is critical. If you treat pain as the problem, you will always be chasing it. But if you begin asking what is driving that signal, you start uncovering the mechanisms that actually create chronic pain.

One of the most overlooked of those mechanisms is the formation of advanced glycation end products.

The Physiology Most Patients Are Never Taught

Normal Function

Under normal conditions, your body tightly regulates blood sugar. Glucose enters the bloodstream after you eat and is used for energy, repair, and normal cellular function.

Proteins throughout your body, such as collagen, enzymes, and receptors, maintain structure and allow tissues to function and communicate properly.

When this system is working well, your body adapts to stress. Tissues remain flexible. Damage is repaired efficiently. Inflammation turns on when needed and turns off when it is no longer necessary.

What Changes with Chronic Pain

When blood sugar is consistently elevated—whether from high sugar intake, refined carbohydrates, or insulin resistance—excess glucose begins circulating in the bloodstream.

What many patients are never told is that this glucose does not remain harmless. It begins binding to proteins in a process called glycation. This reaction is non-enzymatic, meaning your body does not regulate it. It simply occurs when glucose levels are high enough. Once this binding happens, the protein is permanently altered, forming an advanced glycation end product.

Your body cannot reverse this process.

Over time, these damaged proteins accumulate, particularly in neuromuscular tissues (joints, ligaments, tendons, muscles, and nerves), where many chronic pain symptoms are experienced.

How These Changes Produce Symptoms

The critical concept here is that protein structure determines protein function.

When glycation changes the shape of a protein, it can no longer do its job. Collagen, for example, normally provides flexibility and strength to connective tissues. When glycated, it becomes stiff and brittle. Instead of adapting to stress, tissues begin to break down under it.

Enzymes responsible for repairing tissue and regulating inflammation also lose function. This means damage accumulates faster than it can be repaired.

Receptors responsible for communication between cells become less responsive, disrupting coordination across systems.

What this means for patients is a gradual loss of normal tissue function. Stiffness, reduced mobility, slower healing, and persistent irritation that does not resolve the way it should.

This is one of the key ways chronic pain develops without a single identifiable injury.

How AGEs Drive Chronic Inflammation

Another major effect of advanced glycation end products occurs through their interaction with receptors called RAGE (receptor for advanced glycation end products).

Under normal conditions, inflammatory pathways are tightly regulated. They activate when needed and shut down when the job is done.

When AGEs bind to RAGE, this regulation begins to break down. This interaction activates Nf-Kb, one of the body’s primary chronic inflammatory pathways. This increases the production of inflammatory cytokines such as TNF-a, and interleukins, which promote more inflammation.

At the same time, this pathway increases the production of reactive oxygen species, free radicals that damage cells and further amplify inflammation.

What makes this particularly problematic is that this system reinforces itself. Activation of RAGE leads to more RAGE expression, more oxidative stress, and more inflammation.

What this means for patients is inflammation that does not resolve, not because the body “forgot” to turn it off, but because the signal continues to feed itself.

How AGEs Create Hyperexcitable Nerves

Patients are often told their pain is due to “overactive nerves.” This is true, but incomplete.

The real question is why those nerves became overactive.

Nerves are surrounded by a protective insulating layer called the myelin sheath. This insulation allows signals to travel smoothly and prevents excessive firing.

When advanced glycation end products damage this myelin, that insulation begins to break down.

In simpler terms, it is like stripping insulation off an electrical wire. It is only a matter of time before that wire causes a fire.

What this means for patients is increased sensitivity; burning, tingling, or pain from stimuli that should not normally cause discomfort.

This is not random. It is structural and biochemical.

The Brain and Spinal Cord: Amplifying the Signal

Chronic pain is not just about what is happening in tissues. It is also about how the nervous system processes information.

All day long, everything happening inside your body, and outside, compete for your brain's attention. If your brain had to listen to all of it, it would get overwhelmed very quickly. Your spinal cord functions not only to let information into your brain, but to prevent information from reaching it, too. It acts as a filter; only allowing the most important things through.

Advanced glycation end products interfere with this filtering system.

They interact with NMDA receptors in the spinal cord, which act as gates controlling how much pain signal is allowed through. When these receptors are influenced by AGEs, the gate opens more than it should.

This process is known as central sensitization.

What this means for patients is that the body is not necessarily producing more pain signals, but rather the nervous system is allowing more of them through, amplifying the experience of pain.

Additional Nervous System Effects

AGEs can disrupt the blood-brain barrier, which normally protects the brain and regulates the delivery of oxygen and nutrients. When this barrier is compromised, brain cells become stressed and signal distress in the only way they can: by producing pain.

They also increase the expression of TRPV1 receptors, which are responsible for detecting heat and inflammation. This leads to increased calcium influx into nerves and greater release of substance P, a chemical that amplifies pain signals.

What this means for patients is a nervous system that is more reactive, more sensitive, and less capable of filtering out non-threatening stimuli.

Why Standard Treatments Often Fail

When you understand this physiology, it becomes clear why many treatments fall short. Most treatments target pain or inflammation directly. They do not address glycation, blood sugar regulation, or the biochemical changes affecting tissue and nerve function.

So even if symptoms improve temporarily, the underlying drivers remain.

This is why many patients feel stuck in a cycle of temporary relief followed by recurring pain.

Why Imaging Can Look Normal

One of the most frustrating experiences for chronic pain patients is being told that imaging looks normal.

This happens because AGE-related damage is not always structural in a way that imaging can detect. It is biochemical and functional.

Proteins can be altered. Nerves can be sensitized. Communication between systems can be disrupted.

None of this necessarily appears on an MRI.

This does not mean nothing is wrong. It means the problem is occurring at a level most standard tests do not measure.

Multi-System Drivers of Chronic Pain

Advanced glycation end products do not act in isolation.

They sit at the intersection of metabolism, inflammation, nervous system regulation, and connective tissue integrity. This reinforces a central principle: Chronic pain is not a single-system problem. It is a multi-system condition that requires a multi-system understanding.

Reframing Chronic Pain

When you step back and look at the full picture, chronic pain begins to make more sense.

It is not simply due to injury. It is not just inflammation. It is not random nerve behavior. It is the result of cumulative dysfunction across systems—especially biochemical and metabolic systems that are rarely addressed in conventional care.

Advanced glycation end products are one of the clearest examples of how nutrition, metabolism, tissue structure, and nervous system sensitivity all converge to produce chronic pain.

Written By:

Dr. Jason Winkelmann

Naturopathic doctor, Chiropractor, Chronic Pain Specialist, and Educator

Frequently Asked Questions

Are AGEs only a concern for diabetics?

This is one of the most common misunderstandings.

Diabetes is simply the most obvious example of chronically elevated blood sugar, but it is not the only situation where glycation occurs. You do not need to be diabetic to have frequent elevations in blood glucose. Diets high in refined carbohydrates, frequent snacking, poor sleep, chronic stress, and early insulin resistance can all lead to repeated spikes in blood sugar throughout the day.

From a physiological standpoint, glycation is not triggered by a diagnosis—it is triggered by exposure. Every time glucose levels remain elevated for long enough, the probability of that glucose binding to proteins increases. Over time, even mild but repeated elevations can lead to meaningful accumulation of advanced glycation end products.

What this means for patients is that you can be told your labs are “normal” and still be experiencing biochemical changes that contribute to tissue stiffness, inflammation, and pain.

Can the body remove AGEs once they form?

This is where the process becomes particularly important.

Unlike many other biochemical reactions in the body, glycation is largely irreversible. Once a protein has been glycated and an AGE has formed, the body has very limited ability to break it down or repair it. Instead, those altered proteins tend to persist and accumulate over time.

The body can attempt to replace damaged proteins through normal tissue turnover, but this process is slow and depends heavily on the health of the surrounding systems—especially metabolism, circulation, and cellular repair mechanisms. If those systems are already impaired, accumulation outpaces removal.

What this means for patients is that this is not just about short-term exposure. It is about long-term accumulation. The longer the process goes unaddressed, the more it begins to affect tissue quality, nerve function, and inflammatory regulation.

Does this mean diet affects pain?

In many cases, yes—but not in the oversimplified way it is often presented.

Diet does not “cause pain” in a direct, immediate sense. Instead, it influences the biochemical environment your body operates in. Blood sugar regulation, insulin signaling, inflammation, and oxidative stress are all heavily affected by nutritional patterns. These, in turn, influence how tissues function and how the nervous system processes signals.

When blood sugar is frequently elevated, glycation increases. When glycation increases, protein function declines. When protein function declines, tissues become less adaptable, inflammation becomes more persistent, and nerves become more sensitive.

What this means for patients is that diet is not just about weight or general health. It is directly influencing the mechanisms that determine whether your body adapts to stress—or breaks down under it.

Why hasn’t this been part of my treatment before?

This is less about negligence and more about how modern medicine is structured.

Most healthcare systems are divided into specialties—orthopedics focuses on structure, neurology focuses on nerves, endocrinology focuses on metabolism, and so on. Each system is often evaluated in isolation. As a result, connections between systems—like how blood sugar regulation affects nerve sensitivity or connective tissue integrity—are often overlooked in day-to-day clinical care.

Additionally, standard treatment models are built around diagnosing conditions and applying corresponding treatments. This approach works well for acute problems but becomes limited when dealing with chronic, multi-system conditions where there is no single root cause.

What this means for patients is that you may receive accurate pieces of information from different providers, but no one is putting the full physiological picture together. And without that integration, key drivers like advanced glycation end products remain unaddressed.